Implications of the licensure of a partially efficacious malaria vaccine on evaluating second-generation vaccines

BACKGROUND: Malaria is a leading cause of morbidity and mortality, with approximately 225 million clinical episodes and >1.2 million deaths annually attributed to malaria. Development of a highly efficacious malaria vaccine will offer unparalleled possibilities for disease prevention and remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Fowkes, Freya JI, Simpson, Julie A, Beeson, James G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225678/
https://www.ncbi.nlm.nih.gov/pubmed/24228861
http://dx.doi.org/10.1186/1741-7015-11-232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225678/
https://www.ncbi.nlm.nih.gov/pubmed/24228861
http://dx.doi.org/10.1186/1741-7015-11-232

Ejemplares similares